2022
DOI: 10.1055/s-0042-1742381
|View full text |Cite
|
Sign up to set email alerts
|

Devices and Techniques for Percutaneous Creation of Dialysis Arteriovenous Fistulas

Abstract: Dialysis treatment for chronic kidney disease was first developed by Dr. Willem Kolff in 1943, and its availability began to grow in 1962 after which it has become a mainstay treatment for patients with chronic kidney disease. It is estimated that, in 2021, 15% of adults in the United States (∼37 million people) have chronic kidney disease, of which 661,000 individuals have renal failure, and 468,000 individuals require dialysis. There have been several advancements in dialysis treatment since its advent, most… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…Currently, the WavelinQ system and the Ellipsys system, are the two endovascular devices. For the WavelinQ system, a dual catheter plays an important role in creating an anastomosis between the deep artery and vein in the proximal forearm ( 7 ). Whilst the Ellipsys system, is a 6-Fr single-catheter access system that provides heat and pressure to anastomosis between the proximal radial artery and the penetrating vein ( 38 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Currently, the WavelinQ system and the Ellipsys system, are the two endovascular devices. For the WavelinQ system, a dual catheter plays an important role in creating an anastomosis between the deep artery and vein in the proximal forearm ( 7 ). Whilst the Ellipsys system, is a 6-Fr single-catheter access system that provides heat and pressure to anastomosis between the proximal radial artery and the penetrating vein ( 38 ).…”
Section: Discussionmentioning
confidence: 99%
“…In recent years, percutaneous endovascular techniques, WavelinQ (Becton Dickinson, New Jersey) and Ellipsys (Avenu Medical, California), have been used to create AVF with minimal invasiveness ( 7 ). The devices allowed more clinicians to perform AVF independently due to the simple operation, which potentially reduced the waiting time and allowed patients to avoid surgical procedures.…”
Section: Introductionmentioning
confidence: 99%